Mouse Work is one of the most inventive games using the Switch 2’s mouse mode yet. In Mouse Work, up to four players compete to outperform each other at various “jobs” using their Joy-Con mouse ...

Shovel Knight Dig developer Nitrome has announced Mouse Work, a party game for Switch 2 for up to four players that utilizes the hardware’s mouse controls. A release date was not announced. Mouse Work ...

SAN FRANCISCO--(BUSINESS WIRE)--Nitrome Biosciences (Nitrome), a privately-held biopharmaceutical company developing a platform around a newly identified class of enzymes to target Parkinson’s disease ...

Mouse Work is an indie game built around the mouse capabilities of Nintendo Switch 2's controllers, but its developer doesn't even have a Switch 2 dev kit yet. Dev kits are necessary for a game studio ...

Situated in the heart of London's Silicon Roundabout, Nitrome's studio is not entirely what you would expect. While the capital's high-tech business hub conjures images of Google Glass-wearing hipster ...

Nitrome's delightful 2D action-puzzle platformer Bomb Chicken, previously released on the Switch eShop in July last year, will be receiving the physical treatment later this month. Limited Run Games ...

Players take on the role of adorable mice competing to earn Cheddar, the in-game currency, which can be used to unlock cosmetics like hats and bow ties for their mouse cursors. Whether you’re painting ...

The UK developer Nitrome - the team behind Bomb Chicken and also the upcoming release Shovel Knight Dig - has revealed it once pitched a Sonic the Hedgehog game to Sega and was knocked back. According ...

SAN FRANCISCO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc. (formerly Nitrome Biosciences), a biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic ...

Nitrome has announced the Nitrome Classics series, a new range of select titles from Nitrome’s past “lovingly ported from the grund up” to modern platforms like “Switch, Steam, and mobile, with ...

SAN FRANCISCO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Nitrome Biosciences (Nitrome), a privately-held biopharmaceutical company developing a platform around its newly discovered class of enzymes to target ...